Board
Directors
Isao Teshirogi, Ph.D. Representative Director, President and CEO
▼ Reasons for appointment
Isao Teshirogi became Representative Director and President in 2008. He has actively pushed forward with global research and development and expansion of global business to achieve the Third Medium-Term Business Plan and secured a medium- to long-term profit foundation. After achieving the quantitative targets of “Shionogi Growth Strategy 2020 (SGS2020),” formulated in FY2014, he updated the quantitative targets in October 2016 and also achieved these targets ahead of schedule. In 2020, he started a new Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030),” that includes the Company’s vision toward 2030, “Building Innovation Platforms to Shape the Future of Healthcare.” As the path toward realizing the 2030 vision has become clearer due to the plan’s initiatives, he re-established the plan in June 2023 as the “STS2030 Revision” and has vigorously moved forward the business transformation with the aim of achieving further growth.
- April 1982
-
Joined the Company
- January 1999
-
General Manager, Secretary Office and General Manager, Corporate Planning Department
- June 2002
-
Director of the Company
- October 2002
-
General Manager, Corporate Planning Department
- April 2004
-
Executive Officer and Executive General Manager, Pharmaceutical Research & Development Division
- April 2006
-
Senior Executive Officer and Executive General Manager, Pharmaceutical Research & Development Division
- April 2007
-
Senior Executive Officer
- April 2008
-
Representative Director and President and CEO of the Company
- June 2021
-
Outside Director, Sumitomo Mitsui Banking Corporation (incumbent)
- March 2022
-
Outside Director, AGC Inc. (incumbent)
- July 2022
-
Representative Director, President and CEO of the Company (incumbent)
- June 2024
-
Outside Director, Japan Exchange Group, Inc. (incumbent)
- Major concurrent posts
-
Outside Director, Sumitomo Mitsui Banking Corporation
Outside Director, AGC Inc.
Outside Director, Japan Exchange Group, Inc.
Attended all 13 Board of Directors meetings of FY2023.
Takuko Sawada Director and Vice Chairperson of the Board
▼ Reasons for appointment
Since her appointment as a Director of the Company in June 2015, Takuko Sawada has been responsible for business execution of the Corporate Strategy Division as Senior Vice President of the Corporate Strategy Division and as a Senior Executive Officer. She became Vice President in April 2018 and has been supervising the Integrated Disease Care Division, Corporate Strategy Division, Pharmaceutical Commercial Division and DX Promotion Division to achieve the Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030)” and its revised version, “STS2030 Revision,” since April 2020. Furthermore, she has been in charge of supervising management from a higher standpoint as Director and Vice Chairperson since July 2022.
- April 1977
-
Joined the Company
- April 2002
-
Executive General Manager, Pharmaceutical Development Division
- April 2007
-
Officer and Executive General Manager, Pharmaceutical Development Division
- April 2010
-
Executive Officer and Executive General Manager, Pharmaceutical Development Division
- April 2011
-
Senior Executive Officer and Executive General Manager, Global Development Office
- April 2013
-
Senior Executive Officer and Senior Vice President, Global Development and, Pharmaceutical Development Division
- April 2014
-
Senior Executive Officer and Senior Vice President, Global Pharmaceutical Development Division
- April 2015
-
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
- June 2015
-
Director of the Company and Senior Executive Officer and Senior Vice President, Corporate Strategy Division
- October 2015
-
Senior Executive Officer and Senior Vice President, Corporate Strategy Division, and General Manager, Corporate Planning Department
- April 2016
-
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
- April 2017
-
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
- April 2018
-
Director of the Company and Executive Vice President
- Aplil 2020
-
Director of the Company and Executive Vice President and Senior Vice President of Integrated disease care Division
- July 2022
-
Director and Vice Chairperson of the Board (incumbent)
- June 2023
-
Outside Director, Konica Minolta Inc. (incumbent)
- Major concurrent posts
-
Outside Director, Konica Minolta Inc.
Attended all 13 Board of Directors meetings of FY2023.
Outside Directors
Keiichi Ando Outside Director(Independent Director)(Chairperson of the Board of Directors)
▼ Reasons for appointment
Keiichi Ando has practical experience as a corporate executive at a financial institution and broad insight on finance. He also coordinated the extremely difficult adjustments between the national government and the governments of Osaka Prefecture and Osaka City for the airport management business of Kansai, which was then at a crossroads, and his experience and insight built the foundation of Kansai Airports, which plays a leading role in the current Kansai economy. At the Company’s Board of Directors meetings, he presents many questions and opinions and provides sound advice from the perspective of budget planning and management, capital policies, including investments, and risk management to the ensure effective use of important management resources, while, as chair of the Board, taking into account the timeliness and appropriateness of the proposals. Thus, he recognizes the corporate responsibility we should fulfill and makes management decisions with an emphasis on objectivity and impartiality, without bias in favor of corporate executives or specific interested parties.
- April 1976
-
Joined Sumitomo Bank Limited (now Sumitomo Mitsui Banking Corporation)
- April 2003
-
Executive Officer, Sumitomo Mitsui Banking Corporation
- April 2006
-
Managing Executive Officer, Sumitomo Mitsui Banking Corporation
- April 2009
-
Director and Senior Managing Executive Officer, Sumitomo Mitsui Banking Corporation
- April 2010
-
Representative Director and Deputy President and Executive Officer, Sumitomo Mitsui Banking Corporation
- April 2012
-
Representative Director and President, NEW KANSAI INTERNATIONAL AIRPORT COMPANY, LTD
- July 2012
-
Representative Director and President and CEO, NEW KANSAI INTERNATIONAL AIRPORT COMPANY, LTD.
- June 2016
-
Outside Director of the Company (incumbent)
- June 2016
-
Representative Director and President, GINSEN CO., LTD.
- June 2017
-
Outside Director, Tsubakimoto Chain Co. (incumbent)
- June 2019
-
Outside Director, DAIHEN Corporation (incumbent)
- Major concurrent posts
-
Outside Director, Tsubakimoto Chain Co.
Outside Director, DAIHEN Corporation
Attended all 13 Board of Directors meetings of FY2023.
Hiroshi Ozaki Outside Director(Independent Director)
▼ Reasons for appointment
Hiroshi Ozaki has abundant practical experience and wide-ranging knowledge in corporate management and organizational management as a manager of a company based in Kansai. He is also the former chairman of the Osaka Chamber of Commerce and Industry, and during his tenure promoted the economic growth of Osaka and Kansai based on the medium-term plan he developed, as well as focusing on promoting the life science industry. At the Company’s Board of Directors meetings, he raises many pertinent questions and provides sound advice on business matters, including investments and business alliances, as well as marketing and supply chains. Accordingly, he makes management decisions with an emphasis on objectivity and neutrality based on his extensive experience and knowledge.
- May 1972
-
Joined Osaka Gas Co., Ltd.
- June 2000
-
Director, Osaka Gas Co., Ltd.
- June 2002
-
Director and Tokyo Representative, Osaka Gas Co., Ltd., on loan to the Japan Gas Association
- June 2005
-
Managing Director and General Manager of LNG Terminal and Power Generation Business Unit, Osaka Gas Co., Ltd.
- June 2007
-
Managing Director and General Manager of Commercial & Industrial Energy Business Unit, Osaka Gas Co., Ltd.
- April 2008
-
Representative Director and President, Osaka Gas Co., Ltd.
- June 2008
-
Director, Osaka Gas Chemicals Co., Ltd.
- June 2009
-
Representative Director and President, Operating Executive Officer, Osaka Gas Co., Ltd.
- June 2009
-
Director, OGIS-RI Co., Ltd.
- June 2011
-
Outside Director, Asahi Broadcasting Corporation (now Asahi Broadcasting Group Holdings Corporation)
- April 2015
-
Representative Director and Chairman, Osaka Gas Co., Ltd.
- June 2019
-
Outside Director of the Company (incumbent)
- January 2021
-
Director and Senior Advisor, Osaka Gas Co., Ltd.
- June 2021
-
Senior Advisor, Osaka Gas Co., Ltd. (incumbent)
- June 2021
-
Outside Director, The Royal Hotel, Ltd. (incumbent)
- June 2024
-
Outside Director, Hiroshima Gas Co., Ltd. (incumbent)
- Major concurrent posts
-
Outside Director, The Royal Hotel, Ltd.
Outside Director, Hiroshima Gas Co., Ltd.
Attended all 13 Board of Directors meetings of FY2023.
Fumi Takatsuki Outside Director(Independent Director)
▼ Reasons for appointment
Fumi Takatsuki has extensive experience and professional insight from her position as an attorney in international corporate law and in legal response relating to the Chinese life science and healthcare industry. Although she has not been involved in company management in any capacity other than as an outside director in the past, at the Company’s Board of Directors meetings, she presents questions particularly concerning business expansion in Asia, including China, from an international corporate legal perspective, as well as providing sound advice on compliance. Accordingly, she makes fair management decisions from a global perspective, giving priority to legal compliance and social norms.
- October 2000
-
Registration of Attorney at Law
- October 2000
-
Joined Oike Law Offices
- December 2003
-
Joined Anderson Mori & Tomotsune Law Offices
- February 2004
-
Service at Beijing Office of Anderson Mori & Tomotsune Law Offices
- April 2006
-
Joined Oh-Ebashi LPC & Partners
- January 2009
-
Partner, Oh-Ebashi LPC & Partners (incumbent)
- June 2020
-
Outside Director of the Company (incumbent)
- June 2023
-
Outside Corporate Auditor, Sankyo Seiko Co., Ltd. (incumbent)
- June 2024
-
Outside Corporate Auditor, Daikin Industries, Inc. (incumbent)
- Major concurrent posts
-
Partner, Oh-Ebashi LPC & Partners
Outside Corporate Auditor, Sankyo Seiko Co., Ltd.
Outside Corporate Auditor, Daikin Industries, Inc.
Attended all 13 Board of Directors meetings of FY2023.
Takaoki Fujiwara Outside Director(Independent Director)
▼ Reasons for appointment
Takaoki Fujiwara has extensive practical experience and a wide range of knowledge as a manager of a group of companies engaged in urban transport, real estate and entertainment, mainly in the Kansai area. At the Company’s Board of Directors meetings, he provides sound advice, mainly on human resource management and compliance. Accordingly, he makes decisions that emphasize objectivity and neutrality based on his extensive experience and knowledge.
- April 1975
-
Joined Hanshin Electric Railway Co., Ltd.
- June 2005
-
Director, Hanshin Electric Railway Co., Ltd.
- June 2007
-
Managing Director, Hanshin Electric Railway Co., Ltd.
- April 2011
-
Representative Director and President, Hanshin Electric Railway Co., Ltd.
- June 2011
-
Director, Hankyu Hanshin Holdings, Inc.
- April 2015
-
Chairman and Representative Director, Hanshin Hotel Systems, Co., Ltd.
- April 2017
-
Chairman of the Board of Directors and Representative Director, Hanshin Electric Railway Co., Ltd.
- June 2017
-
Representative Director, Hankyu Hanshin Holdings, Inc.
- June 2017
-
Outside Director, Sanyo Electric Railway Co., Ltd.
- December 2017
-
Director, Hanshin Hotel Systems
- June 2018
-
Outside Corporate Auditor of the Company
- April 2023
-
Advisor, Hanshin Electric Railway Co., Ltd. (incumbent)
- June 2023
-
Outside Director of the Company (incumbent)
Attended all 11 Board of Directors meetings of FY2023.
Standing Corporate Auditors
Akira Okamoto Standing Corporate Auditor
▼ Reasons for appointment
Akira Okamoto has served as General Manager of administrative units, including the Business Support Center and the Personnel Department, and is well-versed in corporate management. He provides appropriate recommendations and advice on the management decisions and execution of duties by the Directors from an independent point of view as a Corporate Auditor, leveraging his experience in being involved in enhancing the Company’s corporate governance and upgrading and operating the internal control system as General Manager of the Internal Control Department.
- April 1978
-
Joined the Company
- April 2006
-
General Manager, Business Support Center
- April 2007
-
General Manager, General Affairs & Personnel Department
- April 2008
-
General Manager, Human Resources Department
- April 2011
-
General Manager, Internal Control Department
- June 2015
-
Standing Corporate Auditor of the Company (incumbent)
Attended all 13 Board of Directors meetings of FY2023.
Attended all 11 Board of Corporate Auditors meetings of FY2023.
Noriyuki Kishida Standing Corporate Auditor
▼ Reasons for appointment
Noriyuki Kishida has served as the head of administrative units, including the Corporate Communications Office, the Human Resources Department and the Administration Division, and is well-versed in corporate management and corporate governance. He has extensive experience and a wide range of knowledge in corporate management in general, including management strategies, through his track record in promoting internal reforms based on the management infrastructure strategy of the Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030)” as Senior Vice President of the Corporate Supervisory Unit.
- April 1984
-
Joined the Company
- October 2004
-
General Manager, Corporate Communications Office
- April 2009
-
General Manager, Corporate Communications Office and Secretary Office
- April 2011
-
General Manager, Human Resources Department
- April 2017
-
Corporate Officer and General Manager, Human Resources and General Administration Department
- April 2020
-
Senior Executive Officer and Senior Vice President, Administration Division
- July 2021
-
Senior Executive Officer and Senior Vice President, Administration Division and General Manager of Legal Affairs Department
- July 2022
-
Senior Executive Officer and Senior Vice President, Corporate Supervisory Unit
- June 2024
-
Standing Corporate Auditor of the Company (incumbent)
Outside Corporate Auditors
Tsuguoki Fujinuma Outside Corporate Auditor(Independent Corporate Auditor)
▼ Reasons for appointment
Tsuguoki Fujinuma has professional expertise in finance and accounting. He has held many important posts, including Chairman and President of the Japanese Institute of Certified Public Accountants, and has extensive experience and broad insight as outside director and outside corporate auditor of a wide range of companies. Although he has not been involved in company management in any capacity other than as an outside executive in the past, he performs higher-quality audits of the Company from the perspective of finance and accounting based on his extensive experience as a certified public accountant. He also provides appropriate advice mainly from the finance, accounting, and sustainability viewpoint at the Board of Directors and Board of Corporate Auditors meetings.
Accordingly, we expect him to reflect his experience in the audits of the Company concerning the appropriateness of the management decisions and execution of duties by the directors from an independent point of view as an outside corporate auditor.
- April 1969
-
Joined Horie Morita Accounting Firm
- June 1970
-
Joined Arthur & Young Accounting Firm
- May 1986
-
Partner and Representative Partner, Asahi Shinwa Accounting Firm (now KPMG AZSA LLC)
- July 1993
-
Managing Partner, Ota Showa & Co. (now Ernst & Young ShinNihon LLC) (Resignation in June 2007)
- May 2000
-
President, The International Federation of Accountants (IFAC)
- July 2004
-
Chairman and President, The Japanese Institute of Certified Public Accountants
- February 2005
-
Trustee, The IFRS Foundation Trustees
- July 2007
-
Advisor, The Japanese Institute of Certified Public Accountants (incumbent)
- August 2007
-
Outside Director, Tokyo Stock Exchange Group (now Japan Exchange Group)
- October 2007
-
Governor, Tokyo Stock Exchange Regulation
- April 2008
-
Specially appointed Professor, Chuo Graduate School of Strategic Management (business School)
- June 2008
-
Outside Corporate Auditor, Sumitomo Corporation
- June 2008
-
Outside Corporate Auditor, Takeda Pharmaceutical Company Limited
- June 2008
-
Outside Director, Nomura Holdings, Inc.
- June 2008
-
Outside Director, Nomura Securities Co., Ltd.
- July 2008
-
Outside Director, Sumitomo Life Insurance Company
- February 2009
-
Trustee and Vice Chairman, The IFRS Foundation Trustees
- April 2010
-
Visiting Professor, Kansai University (incumbent)
- May 2010
-
Outside Corporate Auditor, Seven & i Holdings Co., Ltd.
- April 2015
-
Fellow (incumbent) and Advisory Board Member, Chuo University Business School
- July 2017
-
Auditor, Chiba Gakuen Educational Association (incumbent)
- June 2018
-
Chairman of Association, Certified Fraud Examiners Japan
- June 2019
-
Outside Corporate Auditor of the Company (incumbent)
- June 2023
-
Councilor of Association, Certified Fraud Examiners Japan
- Major concurrent posts
-
Auditor, Chiba Gakuen Educational Association
Attended all 13 Board of Directors meetings of FY2023.
Attended all 11 Board of Corporate Auditors meetings of FY2023.
Shuichi Okuhara Outside Corporate Auditor(Independent Corporate Auditor)
▼ Reasons for appointment
Shuichi Okuhara has extensive experience and a wide range of knowledge as a manager of a venture capital firm in a social environment that places importance on innovation through peer or cross-industrial partnerships. He also has professional expertise in finance and accounting as a certified public accountant and carries out audits suitable for the continually changing business environment. At the Board of Directors and Board of Auditors meetings, he provides sound advice, mainly on the healthcare industry in general, including investments and digital technologies. Accordingly, we expect him to reflect his experience in the audits of the Company concerning the appropriateness of the management decisions and execution of duties by the directors from an independent point of view as an outside corporate auditor.
- April 1994
-
Joined Andersen Consulting Co., Ltd. (now Accenture Japan Ltd.)
- January 1998
-
Joined Nippon Venture Capital
- June 2008
-
Director and Investment manager, Nippon Venture Capital
- April 2009
-
Representative Director and President, Nippon Venture Capital
- June 2019
-
Representative Director and Chairman, Nippon Venture Capital (incumbent)
- June 2020
-
Outside Corporate Auditor of the Company (incumbent)
- Major concurrent posts
-
Representative Director and Chairman, Nippon Venture Capital
Attended all 13 Board of Directors meetings of FY2023.
Attended all 11 Board of Corporate Auditors meetings of FY2023.
Yoriko Goto Outside Corporate Auditor(Independent Corporate Auditor)
▼ Reasons for appointment
Yoriko Goto has professional expertise in finance and accounting as a certified public accountant and extensive management experience and broad insight through her service as Chairperson of the Board of Deloitte Tohmatsu Group and Deloitte Touche Tohmatsu LLC, among others. As she also serves as outside director of a financial institution, we believe that she will audit the Company from the finance, accounting, and management viewpoint. Accordingly, we expect her to reflect her experience in the audits of the Company concerning the appropriateness of the management decisions and execution of duties by the directors from an independent point of view as an outside corporate auditor.
- November 1983
-
Joined Deloitte Haskins and Sells International (now Deloitte Touche Tohmatsu LLC)
- June 1996
-
Partner, Deloitte Touche Tohmatsu Limited (now Deloitte Touche Tohmatsu LLC)
- June 2007
-
Japan Leader of Global Financial Services Industry, Deloitte Touche Tohmatsu Limited
- October 2010
-
Managing Partner of Financial Services Industry, Deloitte Touche Tohmatsu LLC
- October 2013
-
Member of Executive Committee of Deloitte Touche Tohmatsu LLC and Member of Board of Deloitte Touche Tohmatsu Limited
- June 2018
-
Chairperson of the Board, Deloitte Touche Tohmatsu LLC and Deloitte Tohmatsu Group, and Member of Board, Deloitte Touche Tohmatsu Limited
- November 2018
-
Member of Board, Deloitte Asia Pacific Limited
- October 2022
-
President, Yoriko Goto CPA Office (incumbent)
- October 2022
-
Outside Director (Member of the Audit and Supervisory Committee) , Sumitomo Mitsui Banking Corporation (incumbent)
- June 2023
-
Outside Corporate Auditor of the Company (incumbent)
- Major concurrent posts
-
Outside Director (Member of the Audit and Supervisory Committee) , Sumitomo Mitsui Banking Corporation
Attended all 11 Board of Directors meetings of FY2023.
Attended all 9 Board of Corporate Auditors meetings of FY2023.
Corporate Officers
Senior Executive Officer, Senior Vice President, Supply Supervisory Unit | Koji Hanasaki, Ph.D. |
---|---|
Senior Executive Officer, Senior Vice President, R&D Supervisory Unit | John Keller, Ph.D. |
Senior Executive Officer, Senior Vice President, Healthcare Business Supervisory Unit | Toshinobu Iwasaki, Ph.D. |
Senior Executive Officer, Senior Vice President, Corporate Supervisory Unit and Corporate Strategy Division | Kazuhiro Hatanaka |
Senior Executive Officer, Senior Vice President, Administration Division | Ryuichi Kiyama, Ph.D. |
Senior Executive Officer, Senior Vice President, Drug Discovery Research Division | Yasuyoshi Isou, Ph.D. |
Senior Executive Officer, President, Shionogi Pharma Co., Ltd | Akira Kato, Ph.D. |
Corporate Officer, Senior Vice President, Corporate Quality Assurance and Ethics & Compliance Management Division | Takeshi Shiota, Ph.D. |
Corporate Officer, Chairman and CEO of Ping An Shionogi Company Ltd. and Ping An Shionogi (Hong Kong) Company Ltd. |
Tatsumori Yoshida |
Corporate Officer, Senior Vice President, DX Promotion Division | Masashi Deguchi, Ph.D. |
Corporate Officer, Senior Vice President, Pharmaceutical Technology Research Division | Yasunori Aoyama, Ph.D. |
Corporate Officer, Senior Vice President, Integrated Disease Care Division | Yousuke Miharu |
Corporate Officer, Senior Vice President, Drug Development and Regulatory Science Division | Takeki Uehara, Ph.D. |
Corporate Officer, Senior Vice President, Pharmaceutical Commercial Division | Yoshinori Yurugi |
Corporate Officer, President, Shionogi Healthcare Co., Ltd | Satoru Yoshimoto |
Corporate Officer, Senior Vice President, Vaccine Business Division | Tetsuya Numa |